Drug Clinical Trials:
News on drug clinical trials, articles on tests or new drugs and medication.
-
Oct 25th, 2008
Minster Pharmaceuticals is pleased to announce positive results from its Phase II trial in Denmark of tonabersat in the prevention of migraine with aura.
-
Oct 24th, 2008
Results from a randomized Phase 2a European study demonstrated that treatment with the investigational drug PTC124 caused statistically significant improvements in the chloride channel function of children with cystic fibrosis caused by a particular genetic mutation, called a nonsense mutation.
-
Oct 24th, 2008
Mpex Pharmaceuticals announced additional clinical and preclinical results with MP-376, the company's novel formulation of levofloxacin inhaled solution delivered by an Investigational eFlow Nebulizer System for use in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD).
-
Oct 23rd, 2008
Isolagen presented an analysis of results from the completed pivotal Phase III studies (Studies IT-R-005 and IT-R-006) of the Isolagen Therapy for the treatment of nasolabial folds, or wrinkles.
-
Oct 18th, 2008
CeNeRx BioPharma has initiated a Phase II clinical trial for its lead product candidate Tyrima for the treatment of major depressive disorder (MDD).
-
Sep 30th, 2008
The first step in addressing the underrepresentation of black Americans in research ... is to recruit more minority physicians into clinical research.
-
Sep 27th, 2008
Why aren't pregnant women included in most clinical trials? It's time to confront the challenges that have led to the exclusion of pregnant women from important research that could positively impact maternal and fetal health.
-
Sep 21st, 2008
Quality assurance programs like the one at the Quality Assurance Review Center (QARC) in Worcester, Mass., strengthen the quality of clinical trials, including cooperative groups conducting National Cancer Institute-supported clinical trials, thereby improving the standard of care in cancer patients.
-
Sep 19th, 2008
A clinical trial comparing psoriasis drugs Ustekinumab made by Johnson & Johnson and Enbrel sold by Wyeth and Amgen shows that Ustekinumab is much better than Enbrel, which currently covers 75% of psoriasis drug market.
-
Sep 11th, 2008
For the first time in more than 80 years a promising live vaccine against tuberculosis has passed into the clinical phase in Germany: Since Monday of this week the new vaccine, which goes by the designation "VPM1002", has begun safety testing on volunteers in a Phase I clinical trial in Neuss, Germany. It is based on a highly safe vaccine that was introduced in 1921.
